EP0233196A4 - Glukoamylase mit expression von hefe. - Google Patents
Glukoamylase mit expression von hefe.Info
- Publication number
- EP0233196A4 EP0233196A4 EP19860903851 EP86903851A EP0233196A4 EP 0233196 A4 EP0233196 A4 EP 0233196A4 EP 19860903851 EP19860903851 EP 19860903851 EP 86903851 A EP86903851 A EP 86903851A EP 0233196 A4 EP0233196 A4 EP 0233196A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- yeast cell
- glucoamylase
- dna
- plasmid
- encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 title claims abstract description 37
- 102100022624 Glucoamylase Human genes 0.000 title claims abstract description 33
- 240000004808 Saccharomyces cerevisiae Species 0.000 title description 26
- 210000005253 yeast cell Anatomy 0.000 claims abstract description 57
- 108020004414 DNA Proteins 0.000 claims description 52
- 239000013612 plasmid Substances 0.000 claims description 51
- 108090000623 proteins and genes Proteins 0.000 claims description 42
- 235000013405 beer Nutrition 0.000 claims description 27
- 210000004027 cell Anatomy 0.000 claims description 24
- 210000000349 chromosome Anatomy 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 18
- 229920002472 Starch Polymers 0.000 claims description 16
- 239000008107 starch Substances 0.000 claims description 13
- 230000009466 transformation Effects 0.000 claims description 9
- 230000001131 transforming effect Effects 0.000 claims description 8
- 241000228245 Aspergillus niger Species 0.000 claims description 7
- 230000010354 integration Effects 0.000 claims description 7
- 235000008429 bread Nutrition 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000019634 flavors Nutrition 0.000 claims description 6
- 230000003115 biocidal effect Effects 0.000 claims description 5
- 238000013518 transcription Methods 0.000 claims description 5
- 230000035897 transcription Effects 0.000 claims description 5
- 108091026890 Coding region Proteins 0.000 claims description 3
- 208000035199 Tetraploidy Diseases 0.000 claims description 3
- 230000003322 aneuploid effect Effects 0.000 claims description 3
- 208000036878 aneuploidy Diseases 0.000 claims description 3
- 238000007747 plating Methods 0.000 claims description 3
- 241000894007 species Species 0.000 claims description 3
- 208000026487 Triploidy Diseases 0.000 claims description 2
- 101150066555 lacZ gene Proteins 0.000 claims description 2
- 230000002759 chromosomal effect Effects 0.000 claims 2
- 239000013599 cloning vector Substances 0.000 claims 2
- 230000001747 exhibiting effect Effects 0.000 claims 2
- 241000228212 Aspergillus Species 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 235000019698 starch Nutrition 0.000 description 15
- 229920001817 Agar Polymers 0.000 description 10
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 10
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 239000012634 fragment Substances 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- 238000010276 construction Methods 0.000 description 9
- 230000004151 fermentation Effects 0.000 description 9
- 230000004927 fusion Effects 0.000 description 9
- 235000015095 lager Nutrition 0.000 description 9
- 229920001542 oligosaccharide Polymers 0.000 description 9
- 150000002482 oligosaccharides Chemical class 0.000 description 9
- 238000000855 fermentation Methods 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 235000015107 ale Nutrition 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 235000021440 light beer Nutrition 0.000 description 5
- 235000015041 whisky Nutrition 0.000 description 5
- BRZYSWJRSDMWLG-DJWUNRQOSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-DJWUNRQOSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 3
- 102100028991 Cytochrome c1, heme protein, mitochondrial Human genes 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 101150043522 HO gene Proteins 0.000 description 3
- 101000916041 Homo sapiens Cytochrome c1, heme protein, mitochondrial Proteins 0.000 description 3
- 101000947508 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Cytochrome c isoform 1 Proteins 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 235000015096 spirit Nutrition 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108010023063 Bacto-peptone Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 101150094690 GAL1 gene Proteins 0.000 description 1
- 102000048120 Galactokinases Human genes 0.000 description 1
- 108700023157 Galactokinases Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 101150017040 I gene Proteins 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 229920002274 Nalgene Polymers 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 208000020584 Polyploidy Diseases 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 235000006085 Vigna mungo var mungo Nutrition 0.000 description 1
- 240000005616 Vigna mungo var. mungo Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000012180 bread and bread product Nutrition 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- -1 corn syrup Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000004897 n-terminal region Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000021309 simple sugar Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C5/00—Other raw materials for the preparation of beer
- C12C5/004—Enzymes
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D8/00—Methods for preparing or baking dough
- A21D8/02—Methods for preparing dough; Treating dough prior to baking
- A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
- A21D8/047—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C11/00—Fermentation processes for beer
- C12C11/003—Fermentation of beerwort
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C12/00—Processes specially adapted for making special kinds of beer
- C12C12/002—Processes specially adapted for making special kinds of beer using special microorganisms
- C12C12/006—Yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
- C12C12/00—Processes specially adapted for making special kinds of beer
- C12C12/02—Beer with low calorie content
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2428—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Definitions
- Beer brewing using yeasts requires the presence of mono-, di-, or tri-saccharides in the fermentation culture medium ("wort"), which the yeasts metabolize in the production of ethanol, C0 2 and other metabolites.
- yeast fermentation starches and complex oligosaccharides (those larger than three glucose units) remain soluble but unmetabolized. These oligosaccharides, which are flavorless and colorless, add only to the caloric content of beer.
- low starch (“light”) beer requires removal of some of the unmetabolized soluble starch and complex oligosaccharides present in the wort that normally remain in the beer after fermentation by yeast.
- Several methods have been used to reduce the content of starch and complex oligosaccharides in low calorie beer:
- the invention features a diploid or greater ploidy yeast cell transformed with DNA encoding glucoamylase, the yeast cell being capable of producing enzymatically active glucoamylase.
- the yeast cell is diploid, triploid, tetraploid, or aneuploid;
- the glucoamylase-encoding DNA is introduced via a plasmid capable of integrating into a chromosome of the host yeast cell via a sequence on the plasmid homologous with a region of a chromosome of the host cell;
- the plasmid is integrated into more than one such homologous region-containing chromosome in the host cell;
- the glucoamylase-encoding DNA is substantially identical to glucoamylase coding sequences of DNA of the mold Aspergillus niger;
- the host yeast cell is a beer brewing strain (most preferably lager) used to brew beer, (e.g., light beer) or is a spirits (e.g
- the plasmids of the invention can be integrated in a way which results in the plasmid DNA remaining substantially intact in the host chromosome, or in a way which results in the jettisoning of unwanted plasmid sequences, e.g., E. coli sequences. In both cases, the plasmid includes a region homologous with a region of the host chromosome.
- the plasmid prior to transformation, is linearized (as it is also in the non-jettisonning case) , and the homologous sequence of the host chromosome has a first and a second end and the plasmid includes a first and a second sequence, respectively homologous with the first and second ends, which sequences are separated from each other by a region of partial non-homology which includes the DNA encoding glucoamylase, a third sequence homologous with the corresponding region of the host chromosome, DNA encoding a selectable trait, and DNA encoding a screenable trait.
- the invention features an improved method of transforming diploid or greater ploidy yeast cells with plasmid DNA involving contacting the cells and the plasmid DNA under transforming conditions, plating the cells on a porous support, and then selecting transformants, the temperature of the yeast cells being maintained below 40 C for the entire period during the transforming and selecting steps.
- the invention makes possible the use of modified forms of the yeast strains normally used in brewing to degrade complex oligosaccharides to produce low-calorie light beer, obviating the addition of exogenous enzyme or diluents, or the use of additional or longer brewing steps, while preserving the distinctive flavor characteristics of the beer imparted by the brewing strain.
- the invention also makes possible an increased yield of distilled ethanol from the fermentation of grain or other starch-containing mashes.
- the invention also reduces the sugar requirement in leavening of bread by yeast.
- Figs. 1 and 3 are diagrammatic representations of plasmids used in the construction of the plasmid of Fig. 2.
- Figs. 2 and 5 are diagrammatic representations of plasmids of the invention.
- Fig. 4 is the nucleotide sequence of a 58-base segment of synthetic DNA used in the construction of said plasmid. Plasmid Components
- plasmids of the invention useful for the transformation of yeast cells for the fermentation of starches in the production of, e.g. light beer, include several components, now discussed in more detail.
- the glucoamylase-encoding DNA used to transform the yeast cells of the invention can be derived from many sources; the most preferred DNA is the glucoamylase gene of the bread mold A_ j _ niger.
- Glucoamylase refers to any exo-enzyme capable of degrading glucose-containing oligosaccharides more than three units in length. As will be described in more detail below, it is not necessary that the enzyme include the entire product of the structural gene which encodes the naturally occurring enzyme; we have shown that a less than complete gene product, encoded by a less than complete structural gene, exhibits glucoamylase activity. In addition, some microorganisms produce more than one form of glucoamylase.
- a ⁇ niger is known to produce two forms of secreted glucoamylase. called GI and GII (Boel et al. (1984) EMBO J. 3_, 1097) .
- Form GI results from the splicing out of four introns at the mRNA level; form GII results from the splicing out of the same four introns plus an addition fifth intron of 169 bases located near the 3' end of the transcript.
- promoter sequences isolated from or substantially identical to yeast promoters, e.g. the promoter naturally controlling transcription of the S_ ⁇ _ cerevisiae triose phosphate isomerase ("TPI") gene.
- a suitable transcription terminator which is also preferably derived from a yeast cell such as £ ⁇ _ cerevisiae, and preferably, but not necessarily, derived from the same gene as the promoter used.
- the vector of the invention be capable of integration into a chromosome of the host yeast cell. This is preferably accomplished by means of a sequence on the vector which is homologous with a sequence (a "target" sequence) of a host chromosome.
- the homologous sequence is a region in which integration will not adversely affect the metabolism and flavor characteristics of the host cell.
- a preferred target region on the host chromosome is the homothallism (HO_) gene, which is advantageously large, and is not related to flavor characteristics of the host yeast.
- vectors of the invention preferably contain a DNA region which encodes a selectable marker protein for the identification of transformants.
- This marker protein can be any protein which can be expressed in host yeast cells and which enables the phenotypic identification of yeast cells which express the protein.
- Preferred marker proteins are proteins which confer resistance to one or more antibiotics, e.g., antibiotic G418.
- Transformants are those cells able to grow in the presence of the antibiotic.
- the yeast cells transformed and cultured according to the invention are diploid or greater ploidy strains used in beer and ale brewing, or in distilled spirits (e.g., whiskey) and bread making.
- S. cerevisiae strains which are "top fermenting” strains, are used in making ales
- S ⁇ uvarum strains which are "bottom fermenting” strains
- Beer and ale brewing strains often are tetraploid, while whiskey and other distillery, and bread strains, are often diploid.
- Other industrial strains are aneuploid, i.e., of a ploidy not an exact multiple of haploid.
- yeast strains used in the invention are those which already are capable of metabolizing simple sugars to produce the desired ale, beer, whiskey, other distilled spirit, or bread product with the characteristic flavor of the product, and which only lack, prior to transformation according to the invention, the ability to metabolize complex oligosaccharides and starches.
- Many suitable yeast strains are publicly available.
- the invention permits the production of light beer or ale without additional steps to remove oligosaccharides.
- the invention permits the use of lower-cost starting materials, i.e. starch rather than sugar, while retaining the desirable flavor characteristics of the fermenting strain.
- Figs. 1-3 the following abbreviations are used for restriction endonuclease cleavage sites: A, Xbal; B, BamHI; Bs, BssHII; E, EcoRI; H, Hindlll; K, Kpnl; L, Bell; M, Smal; P, Pstl; PI, Pvul; PII, PvuII; S, Sail; Sp, Sphl; T, Sstll; U, Stul; X, Xhol.
- A denotes the position of a former Xbal site located about 3 kilobases upstream from the 5' end of the HO gene.
- plasmid pDY3 into which the _9_ niger preglucoamylase gene was inserted, is described in Yocum, _id.
- pDY3 is composed, beginning at the one o'clock position and moving clockwise, of an Xhol to Stul fragment containing a gene fusion of the yeast GAL1 gene and the E ⁇ _ coli lacZ gene; a S al to PvuII fragment including the yeast CYC1 promoter and most of the gene for resistance to the antibiotic G418 from the bacterial transposon Tn903 (the non-essential N-terminal region is not included) ; a PvuII to EcoRI fragment including the _ ⁇ __ coli origin of replication from pBR322 and the amp r gene for selecting transformants in E_ ⁇ coli; and an EcoRI to Xbal fragment of S _ cerevisiae containing the HO gene, including a Kpnl site for the insertion of the A_ ⁇ n
- Fig. 2 illustrates pRDlll, which contains that gene.
- the source of all DNA is indicated on the inner concentric circle.
- Vector Construction The first step was the construction of pDY3 as described in Yocum, ld_. The next step was the isolation of the A_ ⁇ niger preglucoamylase gene. Isolation of the A. niger Preglucoamylase Gene A. niger was grown by shaking 10 spores per liter at 30°C in a medium containing, per liter, 7g Yeast Nitrogen Base (Difco) and 20g Soluble Starch (Fisher) . Mycelium was harvested by filtration after 3 days of growth and total RNA was prepared by the method of Lucas et al. (1977) J. Bacteriol. 130, 1192.
- PolyA-containing irtRNA was isolated by two passes over oligo-dT-cellulose and used to construct a cDNA library by the standard method of G-C tailing into the Pstl site of pBR322 (Maniatis et al. (1982) Molecular Cloning, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.).
- the cDNA library was transformed into E. coli strain YMC9. Single colonies from about 25,000 transformants were screened with a
- pl-19A contained a 2,200 base pair insert that was shown by DNA sequence analysis to contain the entire coding sequence for preglucoamylase I, as described by Boel et al. (1984) EMBO J. 3_, 1097.
- a unique Bell restriction site was located 54 base pairs downstream from the terminaton codon of the preglucoamylase I gene in pl-19A. This site was converted into an Xbal site by standard methods (Maniatis et al. (1982), id) to yield plasmid pRY301 .
- a BssHII to Pstl fragment containing bases 69-746 of the preglucoamylase I coding sequence was cut out of pRY301 and ligated together with a synthetic 58-mer that replaces sequences lost in the subcloning of the BssHII to Pstl fragment (Fig. 4) into the EcoRI to Pstl backbone of pUC8 (New England Biolabs) to give pRDlOl.
- Preglucoamylase was expressed as a fusion protein from the S ⁇ cerevisiae TPI promoter.
- the gene coding for the fusion protein contains DNA including the TPI promoter, the first three amino acids of TPI, an EcoRI linker which creates an isoleucine codon, and preglucoamylase I beginning at the leucine at the sixth position.
- the DNA sequence around the fusion junction is: Met Ala Arg lie Leu Leu... ATG GCT AGA ATT CTA CTC
- the staggered line indicates the EcoRI cleavage site at the fusion junction.
- the gene fusion was constructed as follows.
- pRY271 is an expression vector containing an EcoRI linker inserted at codon three of TPI and a natural Xbal site just upstream from the TPI transcription terminator (Fig. 3). Between the aforementioned EcoRI and Xbal sites was inserted two DNA fragments, the EcoRI-Pstl piece of preglucoamylase cDNA from pRDlOl, and the Pstl-Xbal piece of preglucoamylase cDNA from pRY301. This yielded pRDl05.
- Plasmid pRD105 was cut with Ba HI and Xbal to remove the 3' end of the glucoamylase gene. The resulting fragment was ligated with a synthetic linker of the following sequence: 5' - GATCCTAGTAAC GATCATTGGATC -5', to yield pRDl33.
- Plasmid pRDl33 was designed to encode a protein that is missing the a ino acids covering the fifth intron, as well as a several additional amino acids on both sides of the intron. The linker was designed such that no extraneous amino acid sequences were introduced.
- pRDl33 Upon transformation into yeast, pRDl33 yields a slight increase (about 10%) in glucoamylase activity over pRDl05, so yeast strains containing the shortened version of the glucoamylase gene may be preferred in some instances.
- the shortened version can be easily transferred to the integrating vector pDY3 on a Smal to HindiII fragment, in a manner analogous to the construction of pRDlll from pRDl05 as described above.
- An integrating vector containing the shortened version of the glucoamylase gene can also be constructed from pRDlll as follows. pRDlll can be partially cleaved with BamHI under conditions that give an average of one BamHI cut per molecule.
- Full length linear plasmid can then be separated from circular (uncut) plasmid by standard preparative gel electrophoresis.
- the isolated linear plasmid can then be cleaved with Xbal and ligated with the synthetic linker described above. Transformation of Polyploid Brewing Strains
- the method is as follows.
- Lager strains were isolated from kegs of unpasteurized beer, e.g., Budweiser, by filtration of 500 ml beer through a .45 micron Nalgene disposable filter unit.
- the filter was excised with a sterile scalpel and placed on a petri plate of YEP-D agar (1% Difco Yeast Extract, 2% Difco Bacto-Peptone, 2% dextrose, and 2% agar) containing 20 ug/ml tetracycline and 100 ug/ml ampicillin.
- Yeast colonies appeared in three days.
- the yeast strain was identified as a close relative of Saccharo yces cervisiae by DNA hybridization of 2 micron DNA and HO DNA.
- the lager strains are typically grown to 2 x 10 cells/ml in YEP-D liquid
- Sstll site in HO in the case of pRDlll is mixed with 25 ug of sheared calf thymus DNA in a total volume of 25 to 50 ul LTE and added to a 0.2 ml aliquot of treated cells.
- the mix of DNA and cells is kept on ice for 10 minutes and then is heat shocked in a 38°C water bath for 5 minutes. After 10 more minutes on ice, 1.0 ml of 40% Polyethyleneglycol 4000 in LTE is mixed with the cell suspension. After 30 minutes on ice, the cells are pelleted and resuspended in 0.2 ml YEP-D.
- 0.1 ml of this suspension is spread on a Millipore filter (catalog number HATF 082 25) that has been placed flat on the surface of a YEP-D agar 0.1M KPO., pH 7.0 petri plate. After incubation at 30° for 2 generations (6-8 hours for American lager strains) , the filter containing the yeast cells is transferred to a fresh petri plate of YEP-D agar 0.1M KP0 4 , pH 7.0 plus 200-1000 ug/ml antibiotic G418. Care is taken to avoid bubbles of air between the agar and filters. Transformants appear out the background of untransformed cells as colonies after 3 or 4 days at 30°C.
- the wort contained, per liter, 150 grams of Munton and Fison Amber Malt Extract, 0.5 gram Hallertau Hops Pellets, 0.5 gram Burton Water Salts, and 2.0 grams of Yeast Nutrient Salts (Beer and Wine Hobby, Greenwood, MA 01880).
- a 5% innoculu was grown aerobically to saturation in wort and then added to an anaerobic fermentor. After 9 days of fermentation at 15°C, the raw beer was tranferred to a clean fermenter, leaving behind the bulk of the settled yeast, after which the beer was stored for 3 weeks at 15 C.
- the fermented beer was then analyzed for the presence of dextrins.
- a 1 ml sample of beer was treated with 1 ul of a commercial preparation of A. niger glucoamylase (DIAZYME 200L R , Miles Laboratories) for 3 hours at 50 C. These conditions had been shown to effect complete digestion of any residual dextrins to glucose.
- a 25 ul sample of each digest was then analyzed for glucose on a Yellow Springs Instruments Model 27 glucose analyzer.
- the beer brewed by the transformed strain. Brew 1/pRDlll-R contained substantially reduced levels of dextrin compared to the control beer brewed by untransformed Brew 1.
- Plasmid pRDlll in E. coli YMC9 has been deposited in the American Type Culture Collection, Rockville, MD, and given ATCC Accession No. 53123. Applicants' assignee, BioTechnica International, Inc., acknowledges its responsibility to replace this culture should it die before the end of the term of a patent issued hereon, and its responsibility to notify the ATCC of the issuance of such a patent, at which time the deposit will be made available to the public. Until that time the deposit will be made available to the Commissioner of Patents under the terms of 37 CFR ⁇ 1.14 and 35 ⁇ 112.
- any suitable diploid or greater ploidy yeast can be used in the invention.
- Suitable strains include the ones listed below, all of which contain the HO gene, which facilitates integration.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73645085A | 1985-05-21 | 1985-05-21 | |
| US86478586A | 1986-05-19 | 1986-05-19 | |
| US736450 | 1996-10-24 | ||
| US864785 | 1997-05-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0233196A1 EP0233196A1 (de) | 1987-08-26 |
| EP0233196A4 true EP0233196A4 (de) | 1987-11-30 |
Family
ID=27113051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19860903851 Withdrawn EP0233196A4 (de) | 1985-05-21 | 1986-05-20 | Glukoamylase mit expression von hefe. |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0233196A4 (de) |
| AU (1) | AU5954486A (de) |
| WO (1) | WO1986007091A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1301094C (en) * | 1984-08-31 | 1992-05-19 | Helen Riaboff Whiteley | Bacillus thuringiensis crystal protein gene toxin segment |
| DE3677851D1 (de) * | 1985-08-05 | 1991-04-11 | Merck & Co Inc | Verfahren zur steigerung der produktion von rekombinantem protein in hefearten der gattung saccharomyces. |
| IL80510A0 (en) * | 1985-11-08 | 1987-02-27 | Genetics Inst | Improved yeast strains |
| FR2613727B2 (fr) * | 1986-06-10 | 1990-07-20 | Transgene Sa | Integration dans la souche polyploide saccharomyces uvarum 2285 tg2 amgc du bloc d'expression de l'alpha-amylase de b. licheniformis |
| FR2613726B2 (fr) * | 1986-06-10 | 1990-07-20 | Transgene Sa | Integration dans la souche polyploide de boulangerie (tgf1) du bloc d'expression de l'alpha-amyloglucosidase de aspergillus niger |
| FR2599755B1 (fr) * | 1986-06-10 | 1990-04-20 | Transgene Sa | Bloc d'expression d'une amyloglucosidase dans une levure, levure transformee et procede de preparation d'enzyme |
| DK293787A (da) * | 1986-06-10 | 1987-12-11 | Transgene Sa | Ekspression af en amyloglucosidase |
| US5151354A (en) * | 1986-08-21 | 1992-09-29 | Cornelius Hollenberg | Fermentation processes using amylolytic enzyme producing microorganisms |
| EP0260404B1 (de) * | 1986-08-21 | 1995-05-31 | VAN DEN BERG, Robert | Durch rekombinante DNS-Technologie konstruierte amylolytische enzymproduzierende Mikroorganismen und ihre Verwendung in Gärungsverfahren |
| EP0257115A1 (de) * | 1986-08-21 | 1988-03-02 | Heineken Technisch Beheer B.V. | Durch rekombinante DNS-Technologie konstruierte amylolytische enzymproduzierende Mikroorganismen und ihre Verwendung in Gärungsverfahren |
| FR2615527B1 (fr) * | 1987-05-22 | 1989-08-18 | Lesaffre Soc Ind | Procede d'integration d'une sequence connue d'adn dans les levures ascosporogenes, vecteurs mis en oeuvre et nouvelles souches de levures |
| DE3854256T2 (de) * | 1987-06-06 | 1996-02-01 | Omnigene Inc | Expressionsvektor für hefe. |
| US5190877A (en) * | 1987-09-03 | 1993-03-02 | Gist-Brocades N.V. | Saccharomyces strains for maltose fermentation |
| NL9001388A (nl) | 1990-06-19 | 1992-01-16 | Unilever Nv | Recombinant dna, cel die daarvan afgeleid dna bevat, enzym waarvoor het recombinant dna codeert en toepassingen daarvan. |
| FR2679249B1 (fr) * | 1991-07-15 | 1993-11-26 | Centre Nal Recherc Scientifique | Souches de levure avec integration stable de genes heterologues. |
| US5665585A (en) * | 1992-09-03 | 1997-09-09 | Alko-Yhiot Oy | Recombinant production of glucoamylase P in trichoderma |
| EP3483279A1 (de) | 2011-04-05 | 2019-05-15 | Lallemand Hungary Liquidity Management LLC | Verfahren zur verbesserung der produktausbeute und produkton in einem mikroorganismus durch zugabe von alternierendena elektronenakzeptoren |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0103409A2 (de) * | 1982-08-13 | 1984-03-21 | Zymogenetics, Inc. | Glycolytische Promotoren für regulierte Proteinexpression: Protease-Inhibitor |
| WO1984004539A1 (fr) * | 1983-05-19 | 1984-11-22 | Transgene Sa | Production de la catechol 2,3-oxygenase par des levures, plasmide pour sa mise en oeuvre et application |
| EP0126206A2 (de) * | 1983-01-28 | 1984-11-28 | Cetus Corporation | cDNS für Glucoamylase |
| EP0128743A2 (de) * | 1983-06-07 | 1984-12-19 | Genex Corporation | Expression von Fremdgenen in Hefe |
| EP0139114A2 (de) * | 1983-09-07 | 1985-05-02 | Labatt Brewing Company Limited | Genetisch stabiles allopolyploides somatisches Fusionsprodukt verwendbar in der Herstellung von Alkohol als Brennstoff |
| EP0163491A1 (de) * | 1984-05-22 | 1985-12-04 | Omnigene Inc | Hefevektor |
| WO1986003778A1 (en) * | 1984-12-21 | 1986-07-03 | The Brewing Research Foundation | Precursor polypeptide, dna sequence coding therefor, vectors, host organisms, and processes involving same |
-
1986
- 1986-05-20 AU AU59544/86A patent/AU5954486A/en not_active Abandoned
- 1986-05-20 EP EP19860903851 patent/EP0233196A4/de not_active Withdrawn
- 1986-05-20 WO PCT/US1986/001089 patent/WO1986007091A1/en not_active Ceased
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0103409A2 (de) * | 1982-08-13 | 1984-03-21 | Zymogenetics, Inc. | Glycolytische Promotoren für regulierte Proteinexpression: Protease-Inhibitor |
| EP0126206A2 (de) * | 1983-01-28 | 1984-11-28 | Cetus Corporation | cDNS für Glucoamylase |
| WO1984004539A1 (fr) * | 1983-05-19 | 1984-11-22 | Transgene Sa | Production de la catechol 2,3-oxygenase par des levures, plasmide pour sa mise en oeuvre et application |
| EP0128743A2 (de) * | 1983-06-07 | 1984-12-19 | Genex Corporation | Expression von Fremdgenen in Hefe |
| EP0139114A2 (de) * | 1983-09-07 | 1985-05-02 | Labatt Brewing Company Limited | Genetisch stabiles allopolyploides somatisches Fusionsprodukt verwendbar in der Herstellung von Alkohol als Brennstoff |
| EP0163491A1 (de) * | 1984-05-22 | 1985-12-04 | Omnigene Inc | Hefevektor |
| WO1986003778A1 (en) * | 1984-12-21 | 1986-07-03 | The Brewing Research Foundation | Precursor polypeptide, dna sequence coding therefor, vectors, host organisms, and processes involving same |
Non-Patent Citations (1)
| Title |
|---|
| See also references of WO8607091A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5954486A (en) | 1986-12-24 |
| EP0233196A1 (de) | 1987-08-26 |
| WO1986007091A1 (en) | 1986-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5422267A (en) | Industrial yeast comprising an integrated glucoamylase gene | |
| AU567031B2 (en) | Glucoamylase cdna | |
| US5024941A (en) | Expression and secretion vector for yeast containing a glucoamylase signal sequence | |
| WO1986007091A1 (en) | Yeast expressing glucoamylase | |
| US4794175A (en) | Glucoamylase CDNA | |
| CA1338857C (en) | Yeast vector featuring antibiotic resistance and chromosomal integration | |
| Cole et al. | Stable expression of Aspercillus awamori glucoamylase in distiller's yeast | |
| Steyn et al. | Co-expression of a Saccharomyces diastaticus glucoamylase-encoding gene and a Bacillus amyloliquefaciens α-amylase-encoding gene in Saccharomyces cerevisiae | |
| GB2175590A (en) | Process for the isolation of fermentation products | |
| US5705358A (en) | Process for producing/secreting a protein by a transformed mould using expression/secretion regulating regions derived from a aspergillus endoxylanase II gene | |
| CA1340101C (en) | Amylolytic enzymes producing microorganisms, constructed by recombinant dna technology and their use for fermentation processes | |
| US5100794A (en) | Amylolytic enzymes producing microorganisms, constructed by recombinant DNA technology and their use for permentation processes | |
| US6214577B1 (en) | Yeast vectors conferring antibiotic resistance | |
| AU687852B2 (en) | Glucoamylase promoter obtained from neurospora crassa and its use in the production of heterologous polypeptides | |
| US5151354A (en) | Fermentation processes using amylolytic enzyme producing microorganisms | |
| CA1316472C (en) | Yeast expressing glucoamylase | |
| JP2607509B2 (ja) | グルコアミラーゼ生産形質転換酵母によるアルコールの生産方法 | |
| JP4189317B2 (ja) | デンプンからアルコールを製造する方法 | |
| Ashikari et al. | Alcohol Production fey Genetically Improved Yeast | |
| US5045463A (en) | DNA expression vector and use thereof | |
| JPH07171A (ja) | 酒類の製造法 | |
| JP2006238852A (ja) | ペプチド輸送酵素遺伝子による酵母の形質転換法と当該遺伝子のプロモーター領域を用いたタンパク質の発現法 | |
| NZ219435A (en) | Production of glucoamylase by recombinant techniques | |
| IE64478B1 (en) | Process and signal sequence for the extracellular production of proteinaceous material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19870414 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 19871130 |
|
| 17Q | First examination report despatched |
Effective date: 19900719 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Withdrawal date: 19910125 |
|
| R18W | Application withdrawn (corrected) |
Effective date: 19910125 |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: YOCUM, ROBERT, ROGERS Inventor name: CHEN, MICHAEL, C. Inventor name: DAVES, ROBERT, S. |